Tumorigenic potential of circulating tumor cells in pulmonary venous blood from Non-Small Cell Lung

来源 :第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 | 被引量 : 0次 | 上传用户:ctrl111shift
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To explore the clinical value and biological characteristics of circulating tumor cells (CTCs) in pulmonary vein (CTCs-pv) from patients with surgically resected non-small cell lung cancer (NSCLC).Method: The number of CTCs per 7.5ml in pulmonary venous and peripheral blood from 32 patients undergoing completed tumor resection was detected by using CellSearch system respectively.Correlation between CTCs-pv, CTCs-peri count and clinical pathological variables were tested for significance.
其他文献
目的:超极化激活环核苷酸门控阳离子通道(HCN)参与心脏起搏,疼痛,癫痫等生理病理活动.在人类的窦房结(SAN),HCN4是HCN家族的中最丰富的亚型,而且自2003年起,对HCN4基因几个失去功能的突变体的研究表明,HCN4与窦房结功能障碍关联重大.因此HCN通道阻滞剂是在心脏疾病的治疗的新方法,如伊伐布雷定被批准用于治疗稳定型心绞痛.本论文旨在构建超极化激活环核苷酸门控阳离子通道(HCN)亚型
会议
Objective: Influenza is one of the major global plagues, and to date there are only two types of effective antiviral agents against it in clinic (M2 inhibitors and NA inhibitors).
Morusin is a prenylated flavonoid that was firstly isolated from the root bark of Morus alba L., possesses anti-HIV, anti-oxidant, anti-inflammatory and anti-tumor activities.
Background: Filamentous microorganisms such as filamentous fungi and bacteria are represented as one of the major sources for bioactive compounds, especially for lead identification in medical science
Semen-derived enhancer of viral infection(SEVI), made up of residues 248-286 of prostatic acidic phosphatase (PAP248-286), is composed of amyloid fibrils that can greatly enhance HIV-1 infectivity and
Influenza virus remains to pose a direct threat to human beings and society for causing severe epidemics of respiratory illness, and highlights an urgent need for new anti-influenza drugs.
Although the current combined anti-retroviral therapy (cART) could successfully control HIV viraemia in infected patients under the detectable level, it fails to completely eradicate the pathogen.
目的:目前尚无低剂量131I用于治疗低刺激性Tg、不伴有远处转移的高危分化型甲状腺癌的相关研究,本研究旨在探讨低剂量131I在这部分人群中的清甲效果.方法:纳入本回顾性研究的标准为:1)年龄>18岁;2)分化型甲状腺癌全切术后;3)T4分期(术中肉眼可见甲外侵犯),任何N分期;4)清甲治疗前刺激性Tg≤5ng/ml;5)无远处转移的证据;6)TgAb≤46IU/ml.这部分患者在TSH刺激状态下(
会议
Objective: AZD9291 is an oral, potent, irreversible EGFR-TKI, selective for sensitizing (EGFRm+) and T790M resistance mutations, currently under investigation in an ongoing Phase Ⅰ study of pts with E
会议
Objective: Dacomitinib (D) is an irreversible pan-HER kinase inhibitor.The ARCHER 1009 global phase Ⅲ study compared D and erlotinib (E) as treatment for locally advanced/metastatic non-small cell lun
会议